Max Chat
Company Analysis Ajanta Pharma Limited
1. Summary
Advantages
- Current debt level 0.787% is below 100% and has decreased over 5 years from 1.31%.
- The company's current efficiency (ROE=25.02%) is higher than the sector average (ROE=17.27%)
Disadvantages
- Price (2635.65 βΉ) is higher than fair price (927.91 βΉ)
- Dividends (0.844%) are below the sector average (11.45%).
- The stock's return over the last year (-11.28%) is lower than the sector average (28.42%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Ajanta Pharma Limited | Index | ||
|---|---|---|---|
| 7 days | 1.5% | -17.9% | 3.3% |
| 90 days | 6.8% | -12.5% | 8.3% |
| 1 year | -11.3% | 28.4% | 6.1% |
AJANTPHARM vs Sector: Ajanta Pharma Limited has significantly underperformed the "" sector by -39.7% over the past year.
AJANTPHARM vs Market: Ajanta Pharma Limited has significantly underperformed the market by -17.36% over the past year.
Stable price: AJANTPHARM is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AJANTPHARM with weekly volatility of -0.2169% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2635.65 βΉ) is higher than the fair price (927.91 βΉ).
Price is higher than fair: The current price (2635.65 βΉ) is 64.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (40.13) is lower than that of the sector as a whole (45.97).
P/E vs Market: The company's P/E (40.13) is lower than that of the market as a whole (44.6).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (9.75) is higher than that of the sector as a whole (6.33).
P/BV vs Market: The company's P/BV (9.75) is higher than that of the market as a whole (5.33).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.95) is higher than that of the sector as a whole (5.18).
P/S vs Market: The company's P/S indicator (7.95) is lower than that of the market as a whole (8.99).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (20.66) is higher than that of the sector as a whole (13.54).
EV/Ebitda vs Market: The company's EV/Ebitda (20.66) is higher than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 8.15% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (8.15%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-29.74%).
5.4. ROE
ROE vs Sector: The company's ROE (25.02%) is higher than that of the sector as a whole (17.27%).
ROE vs Market: The company's ROE (25.02%) is higher than that of the market as a whole (-1.52%).
5.5. ROA
ROA vs Sector: The company's ROA (19.07%) is higher than that of the sector as a whole (10.24%).
ROA vs Market: The company's ROA (19.07%) is higher than that of the market as a whole (7.42%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (10.89%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.44%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.844% is below the average for the sector '11.45%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.844% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0.844% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (37.96%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
